Scottsdale, AZ -- (SBWIRE) -- 03/06/2013 -- universalpennystocks.com focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny Stocks could offer the greatest potential return on your short or long term investment. Sign up for our free newsletter before you miss the next alert.
Acura Pharmaceuticals, Inc.(NASDAQ:ACUR) shares went 48.29% up and closed at $3.04 in the last trading session after news that the chain drug store KERR DRUG will now stock its new next generation pseudoephedrine with abuse deterrent technology. Nexafed [pseudoephedrine hydrochloride (HCl)] is a decongestant which is designed to be more difficult to use in the manufacture of methamphetamine without sacrificing efficacy. The company started selling Nexafed in December, with a focus on independent drug store chains.
The company disclosed that Kerr's about 75 locations in North Carolina will carry its product. Acura also said on Monday, when it reported its fourth-quarter earnings, that it has signed distribution deals for Nexafed with most regional and national drug wholesalers.
Why Should Investors Buy ACUR After The Recent Gain? Just Go Here and Find Out
Its overall traded volume was 8.64 million shares. The stock’s opening price was $2.30, hitting the day high price of $3.62 and day low of $2.29. ACUR has earnings per share of -$0.17. The company has -23.71% returns on assets, -24.33% returns on equity and its return on investments is -24.33%.
Elan Corporation, plc (ADR) (NYSE:ELN) climbed +0.51% to close at $11.87 and its total volume in the last trading session was 6.21 million shares. The company recently stated that it plans to introduce a "unique" dividend policy, under which it will pay a disbursement to its shareholders directly from the monies generated by Tysabri, a multiple sclerosis drug it developed and ultimately sold to its partner Biogen. The dividend to be paid will represent a certain percentage of the royalties Biogen pays for Tysabri, and the company predicts to make two distributions per year.
In last 52 weeks, high hit was $11.89 and low price in that period was $11.65. The company has outstanding shares of 594.95million with the total market cap of $7.06 billion and its beta value stands at 0.99 times. It has current ratio of 3.92 and its debt-to-equity ratio is 0.97.
Will ELN Continue To Move Higher? Find Out Here
Delcath Systems, Inc.(NASDAQ:DCTH) fell -4.52% and closed at $1.69 with the total traded volume of 2.89 million shares, one day after its participation at Cowen Health Care Conference. Its opening price was $1.77 and its shares traded within the range of $1.67-$1.83.
This company has earnings per share of -$1.07 with the net profit margin of -38684.04% and operating margin of -39740.73%. The company now has market cap of about $129.83million.
Why Should Investors Buy DCTH After the Recent Fall? Just Go Here and Find Out
About Universal Penny Stocks
universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)